To investigate the underlying reasons, a PLC GWAS conducted by James et al. in 2017 demonstrated significant genomic differences between LUAD and LUSC, despite both belonging to NSCLC, suggesting potential distinct mechanisms for the development of LUAD and LUSC [13]. Here, HSPG2 is linked to non-small cell lung carcinoma.